Drug Type Biological products |
Synonyms |
Target |
Action inhibitors |
Mechanism ADAMTS5 inhibitors(ADAMTS5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis, Knee | Phase 2 | United States | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | Denmark | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | Australia | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | Spain | 09 Nov 2022 | |
Osteoarthritis, Knee | Phase 2 | France | 09 Nov 2022 |